The recent proliferation of increasingly sophisticated murine models of chronic, relapsing intestinal inflammation and new techniques to target genetic deletions and insertions to discrete cell types have dramatically improved our ability to more precisely evaluate mechanisms of immune-mediated intestinal inflammation and mucosal homeostasis. In parallel, non-mammalian animal models such as zebrafish have facilitated high-resolution in vivo imaging and expeditious, cost-effective manipulation of target genes, leading to rapid discovery of new gene functions and entirely novel pathways regulating homeostasis and response to injury. These increasingly relevant and sophisticated animal models have allowed investigators to very rapidly and precisely address pathogenic and protective pathways, to perform preclinical studies that lay the foundation for highly effective human translational research and dramatically accelerate the search for novel therapeutic agents for inflammatory bowel diseases (IBD) and other inflammatory disorders. However, to create compound mutant and reporter strains, the degree of complexity and the need for very complicated breeding strategies with resultant increased per diem costs have placed many of these potentially useful models out of range for investigators with traditional ROl grant support, whose budgets typically have limited supply and per diem resources. The Animal Models Core centralizes breeding, development, and maintenance of these extraordinarily useful but complex animal models into a single unit that increases efficiency, decreases costs for Program Project investigators and prevents phenotype variation between investigators by providing a single environment for each centrally housed line. The Animal Models Core leverages exceptional specific pathogen free and gnotobiotic animal facilities and expert personnel to provide high-quality essential resources and services to all four Projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK094779-02
Application #
8737242
Study Section
Special Emphasis Panel (ZDK1-GRB-6)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
2
Fiscal Year
2014
Total Cost
$257,903
Indirect Cost
$98,362
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Huang, Juin-Hua; Liu, Chu-Yu; Wu, Sheng-Yang et al. (2018) NLRX1 Facilitates Histoplasma capsulatum-Induced LC3-Associated Phagocytosis for Cytokine Production in Macrophages. Front Immunol 9:2761
Weiser, Matthew; Simon, Jeremy M; Kochar, Bharati et al. (2018) Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut 67:36-42
Cronan, Mark R; Matty, Molly A; Rosenberg, Allison F et al. (2018) An explant technique for high-resolution imaging and manipulation of mycobacterial granulomas. Nat Methods 15:1098-1107
Ellermann, Melissa; Sartor, R Balfour (2018) Intestinal bacterial biofilms modulate mucosal immune responses. J Immunol Sci 2:13-18
Pushalkar, Smruti; Hundeyin, Mautin; Daley, Donnele et al. (2018) The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov 8:403-416
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Vázquez-Baeza, Yoshiki; Gonzalez, Antonio; Xu, Zhenjiang Zech et al. (2018) Guiding longitudinal sampling in IBD cohorts. Gut 67:1743-1745
Ho, G-T; Aird, R E; Liu, B et al. (2018) MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal Immunol 11:120-130
Keith, Benjamin P; Barrow, Jasmine B; Toyonaga, Takahiko et al. (2018) Colonic epithelial miR-31 associates with the development of Crohn's phenotypes. JCI Insight 3:
Sartor, R Balfour; Wu, Gary D (2017) Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology 152:327-339.e4

Showing the most recent 10 out of 35 publications